Imagi International Holdings Limited
| Formerly known as |
Until |
| IMI Global Holdings Limited |
30-Mar-04 |
| Boto International Holdings Limited |
13-Nov-02 |
CITIC Pacific/ CLP AGM Roundup
It was a CITIC Pacific AGM with a few surprises - a Boto (0585) independent
director reveals for the first time that he did not regard last year's deal as
fair and reasonable - so why didn't he say so at the time? Meanwhile Project
Vampire bites, as the public vote, excluding insiders, appears to be against the
general mandate by a 55% majority. And we take a brief look at the CLP meeting.
(6-May-03)
The
Foxes Guarding Hong Kong's Hens
BusinessWeek, 26-Aug-02
Hong
Kong's Cautionary Christmas Carol
BusinessWeek, 23-Aug-02
Webb
shares thoughts on Boto sale
FinanceAsia, 20-Aug-02
Christmas is Cancelled
After a 5 month Battle of Boto, the deal goes ahead in a vote won by the
narrowest of margins, and only because it was stacked with management-related
votes, by kind permission of the Stock Exchange of Hong Kong. Over three
quarters of the public votes were against the deal. Will minorities ever get a
level playing field in Hong Kong? For now, they have an unlevel minefield.
(19-Aug-02)
Time to Vote Against Boto Sale
Boto's
circular is finally out, and in a move unique in recent history, the
Independent Financial
Adviser advises shareholders to vote AGAINST the sale! It
underlines how unfair the proposal is. The circular also reveals evidence
that contrary to the 9.6% reported earnings drop, Boto's core business
actually increased profits 12.5% last year, as we will show. We tell you
how and why you should vote against the sale. (4-Aug-02)
Breach
of Listing Rules
Company announcement, 17-Jul-02
Boto's New Deal
Boto has at last
announced amended terms for the proposed sale of its core businesses. We
give our views. (12-Jul-02, revised 13-Jul-02)
Minority
Uprising
Time Magazine, 27-May-02
Mobius
decries lack of investor protection
HK-iMail, 24-May-02
Don't Stack the Boto Vote
The Boto saga drags on,
and it now emerges that, in the knowledge that the Buy-out plan has no
support from independent investors, Management is trying to stack the vote
by appealing again to a key committee of the Stock Exchange to allow
insiders to vote. We urge the Listing (Review) Committee not to waver, and
to allow the proposal, if it proceeds, to be put to truly independent
shareholders. (9-May-02)
A Fair Alternative for Boto
In the Boto Buy-out case,
the SEHK has reportedly confirmed that other directors are conflicted from
voting, while allowing senior managers and a trust run by HSBC to vote -
even though the managers report to Mr Kao and HSBC if financing the
Buy-out. Among other minority shareholders is the parent of Shanghai
Industrial, which has a director on the board. We again urge Boto to
withdraw the proposal, which faces near-certain defeat. We reveal that
investors opposed
to the Buy-out have proposed an alternative which would be fair to all.
(28-Apr-02)
All
might not be merry with buyout plan
International Herald Tribune, 23-Apr-02
A
letter from David Webb
FinanceAsia.com, 11-Apr-02
Carlyle
LBO's Xmas
FinanceAsia.com, 10-Apr-02
Templeton Rejects Boto Buyout Plan
The largest institutional
investor in Hong Kong stocks, Templeton, has announced its opposition to
the Boto MBO proposal and urged all other shareholders, large and small to
vote against the deal. (8-Apr-02)
Say No to Boto's MBO
Boto, the World's leading
artificial Christmas tree maker, has been growing a perfect seasonal
balance in leisure furniture. Now just as that is soaring,
along comes the Chairman with a management buy-out offer backed by Carlyle
Group, at an estimated 5.6x Mar-02 earnings, leaving shareowners with a
shrunken shell and a start-up graphics animator. The deal requires
minority shareholders' approval. We regard the offer as derisory and urge
investors to vote against the deal, as we and a number of institutions
intend to do. (4-Apr-02)
The 2001 Christmas Pick
Ho ho ho!
No, that's not a list of Shun Tak directors - it's the sound of Santa
Claus and time for Webb-site.com's annual gift to our
readers, a small-cap delight to put in your stockings. Like Christmas, our
stock tip comes just once a year. Last year's pick, Kingmaker, returned
53.2%, beating the HSI by 84.8%. Our 1999 pick returned 81.6% in two
years. So what's in our sack for this year? Read
on to find out. (3-Dec-01)
Oh
Tannenbaum, How Your Fiber-Optic Needles Glow
BusinessWeek, 2-Jan-01
A Load of Cobblers
It's nearly Christmas, and time for Webb-site.com's annual gift to our
readers, a small-cap delight to put in your stockings. At last - something
positive from the gloomiest site in town! Last year's pick, Boto International,
outperformed the HSI by 32.6% in a year. Read on to see who gets our vote this
year. (4-Dec-00)
SFC
prosecutes Mr Lawrence Lai Chi Kin for Contravening the Securities (Disclosure of
Interests) Ordinance
SFC, 19-Sep-00
Deck the Halls with Boto
Christmas is coming, and with only 19 shopping days left (and even fewer market
days) we're getting into the festive spirit. So for once, we'll write something
positive about an overlooked HK company that makes a large portion of North
America's artificial Christmas trees. (5-Dec-99)
Sign up for our free newsletter
Recommend Webb-site.com to a friend
Important notice: All material on this site, except
where otherwise accredited, is copyright to Webb-site.com.
Media and researchers are welcome to quote from articles on this site, provided that such
quotation is attributed to Webb-site.com. The
information in this site should not be relied upon by any person in making any investment
decision. No responsibility or liability is accepted by Webb-site.com or any person
related to it for any loss arising from or in reliance upon the whole or any part of the
contents of this site. Persons who are in any doubt about an investment or potential
investment should take professional investment advice. From time to time parties associated with Webb-site.com may
own long or short positions in securities issued by or related to companies or governments
on which we comment.
Back to top
|